Evidence map›Paper›PMID 36038806›Full record

ArticleDermatologic therapy2022

Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma.

Sarah Demouche, Pierre-Antoine Juge, Pierre Charles, Vincent Descamps, Khadija Benali, Florence Brunet-Possenti

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sarah DemoucheDepartment of Dermatology, Hôpital Bichat, AP-HP, Paris, France.
Pierre-Antoine JugeDepartment of Rheumatology, Hôpital Bichat, AP-HP, Université de Paris, Paris, France.
Pierre CharlesDepartment of Internal Medicine, Institut Mutualiste Montsouris, Université de Paris, Paris, France.
Vincent DescampsDepartment of Dermatology, Hôpital Bichat, AP-HP, Paris, France.
Khadija BenaliDepartment of Nuclear Medicine, Hôpital Bichat, AP-HP, Université de Paris, Paris, France.
Florence Brunet-PossentiDepartment of Dermatology, Hôpital Bichat, AP-HP, Paris, France.
Hôpital Bichat-Claude-Bernard · FRInstitute Mutualiste Montsouris · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Sarcoma, KaposiAntibodies, Monoclonal, HumanizedHumansAntibodies, Monoclonal, Humanizedtocilizumab

Identifiers

PMID36038806
PMCPMC9786762
OpenAlexW4293679658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.